Roger Adsett Insmed Inc (INSM) insider trading activity

INSM Quotes by TradingView

Roger Adsett is Chief Operating Officer of INSMED Inc. Currently has a direct ownership of 149,275 shares of INSM, which is worth approximately $11.1 Million. The most recent transaction as insider was on May 17, 2024, when has been sold 5,945 shares (Common Stock) at a price of $25.09 per share, resulting in proceeds of $149,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 149K
0% 3M change
1.37% 12M change
Total Value Held $11.1 Million

Roger Adsett Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
SELL
Open market or private sale
$149,160 $25.09 p/Share
5,945 Reduced 3.83%
149,275 Common Stock
May 14 2024
SELL
Open market or private sale
$200,353 $25.5 p/Share
7,857 Reduced 4.82%
155,220 Common Stock
May 13 2024
BUY
Grant, award, or other acquisition
-
14,518 Added 8.17%
163,077 Common Stock
Jan 12 2024
SELL
Open market or private sale
$150,336 $28.63 p/Share
5,251 Reduced 3.41%
148,559 Common Stock
Jan 10 2024
SELL
Open market or private sale
$102,190 $28.9 p/Share
3,536 Reduced 2.25%
153,810 Common Stock
Jan 09 2024
SELL
Open market or private sale
$112,232 $29.25 p/Share
3,837 Reduced 2.38%
157,346 Common Stock
Jan 05 2024
SELL
Open market or private sale
$88,856 $29.21 p/Share
3,042 Reduced 1.85%
161,183 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
12,873 Added 7.27%
164,225 Common Stock
Jun 13 2023
SELL
Open market or private sale
$173,512 $19.32 p/Share
8,981 Reduced 5.6%
151,352 Common Stock
May 17 2023
SELL
Open market or private sale
$44,357 $18.12 p/Share
2,448 Reduced 1.5%
160,333 Common Stock
May 16 2023
SELL
Open market or private sale
$27,971 $18.39 p/Share
1,521 Reduced 0.93%
162,781 Common Stock
May 15 2023
SELL
Open market or private sale
$54,861 $19.27 p/Share
2,847 Reduced 1.7%
164,302 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
31,662 Added 15.93%
167,149 Common Stock
Jan 10 2023
SELL
Open market or private sale
$57,460 $17.99 p/Share
3,194 Reduced 2.3%
135,487 Common Stock
Jan 05 2023
SELL
Open market or private sale
$60,119 $19.75 p/Share
3,044 Reduced 2.27%
131,083 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
7,598 Added 5.19%
138,681 Common Stock
Nov 22 2022
SELL
Open market or private sale
$222,874 $18.8 p/Share
11,855 Reduced 8.12%
134,127 Common Stock
May 17 2022
SELL
Open market or private sale
$41,127 $20.34 p/Share
2,022 Reduced 1.37%
145,982 Common Stock
May 16 2022
SELL
Open market or private sale
$25,719 $18.45 p/Share
1,394 Reduced 0.93%
148,004 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
27,460 Added 15.53%
149,398 Common Stock
Jan 12 2022
SELL
Open market or private sale
$29,914 $24.58 p/Share
1,217 Reduced 0.99%
121,938 Common Stock
Jan 06 2022
SELL
Open market or private sale
$45,734 $26.0 p/Share
1,759 Reduced 1.64%
105,420 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
17,735 Added 12.59%
123,155 Common Stock
Jan 05 2022
SELL
Open market or private sale
$84,707 $27.61 p/Share
3,068 Reduced 2.78%
107,179 Common Stock
May 15 2021
SELL
Payment of exercise price or tax liability
$64,972 $26.23 p/Share
2,477 Reduced 2.2%
110,247 Common Stock

Also insider at

LABP
Landos Biopharma, Inc. Healthcare
RA

Roger Adsett

Chief Operating Officer
Bridgewater, NJ

Track Institutional and Insider Activities on INSM

Follow INSMED Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

News

Receive news related to INSMED Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INSM